JFA
JNBA Financial Advisors Portfolio holdings
AUM
$1.04B
This Quarter Return
+6.86%
1 Year Return
+13.36%
3 Year Return
+46.06%
5 Year Return
+82.07%
10 Year Return
+153.44%
AUM
$952M
AUM Growth
+$952M
(+8.3%)
Cap. Flow
+$66.6M
Cap. Flow
% of AUM
7%
Top 10 Holdings %
Top 10 Hldgs %
47.38%
Holding
737
New
25
Increased
65
Reduced
204
Closed
69
Top Buys
Top Sells
Sector Composition
| 1 | Technology | 3.36% |
| 2 | Financials | 3.08% |
| 3 | Industrials | 2.53% |
| 4 | Healthcare | 1.83% |
| 5 | Consumer Discretionary | 0.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
726
Qiagen
QGEN
$10.1B
| – | – |
-12
| Closed | -$522 |
|
727
Schwab US REIT ETF
SCHH
$8.24B
| – | – |
-116,328
| Closed | -$2.41M |
|
728
ALPS Sector Dividend Dogs ETF
SDOG
$1.23B
| – | – |
-225
| Closed | -$11.5K |
|
729
Global X Silver Miners ETF NEW
SIL
$2.9B
| – | – |
-500
| Closed | -$14.2K |
|
730
SPDR Portfolio Aggregate Bond ETF
SPAB
$8.56B
| – | – |
-1,376
| Closed | -$35.3K |
|
731
Sarepta Therapeutics
SRPT
$1.98B
| – | – |
-4
| Closed | -$386 |
|
732
Stratasys
SSYS
$863M
| – | – |
-33
| Closed | -$472 |
|
733
Theravance Biopharma
TBPH
$691M
| – | – |
-1
| Closed | -$12 |
|
734
Teradata
TDC
$1.96B
| – | – |
-40
| Closed | -$1.74K |
|
735
Vanguard High Dividend Yield ETF
VYM
$63.6B
| – | – |
-300
| Closed | -$33.5K |
|
736
NCR Voyix
VYX
$1.76B
| – | – |
-40
| Closed | -$677 |
|
737
Xylem
XYL
$34B
| – | – |
-150
| Closed | -$17.2K |
|